Showing results (1451-1460 of 1,557) with videos related to
Sort By:
Pageof 156
Cancer Research|October 19, 2010
Inhibition of ALK, PI3K/MEK, and HSP90 in murine lung adenocarcinoma induced by EML4-ALK fusion oncogeneZhao Chen, Takaaki Sasaki, Xiaohong Tan, et al.Blood|May 7, 2016
Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphomaJulie Marie Matthews, Shruti Bhatt, Matthew P Patricelli, et al.Cancer Discovery|September 11, 2012
Reactivation of ERK signaling causes resistance to EGFR kinase inhibitorsDalia Ercan, Chunxiao Xu, Masahiko Yanagita, et al.Cancer Cell International|December 11, 2025
Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot studyMike Wu, Daniël P de Bruyn, Ruben G Boers, et al.Blood|June 16, 2021
The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistanceGuang Yang, Jinhua Wang, Li Tan, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.Journal of Medicinal Chemistry|August 11, 2015
Development of Selective Covalent Janus Kinase 3 InhibitorsLi Tan, Koshi Akahane, Randall McNally, et al.Virology Journal|December 4, 2013
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary modelsMiguel Lacerda, Penny L Moore, Nobubelo K Ngandu, et al.Nature Chemical Biology|March 13, 2026
A druggable redox switch on SHP1 controls macrophage inflammationMei Ying Ng, Meredith N Nix, Guangyan Du, et al.Science Translational Medicine|August 19, 2016
Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regenerationFuqin Fan, Zhixiang He, Lu-Lu Kong, et al.Pageof 156